According to the analysis of the expression patterns of plasma TF as well as the correlation between plasma TF expression and NSCLC patients' prognosis and clinicopathologic features, we further conducted experiments both in vitro and in vivo, and found TF knockdown could inhibit the ability of NSCLC cell proliferation, invasion and migration. The gene discussed is TF; the disease is non-small cell lung carcinoma.